UNIVERSITY OF NEW MEXICO

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1889-01-01

Employees: 6.7K

Market Cap: -

Website: https://www.unm.edu/

Clinical Trials

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

Phase 2

Completed

Conditions: Non-Hodgkin's Lymphoma
Cancer

First Posted Date: 2006-01-12

Last Posted Date: 2010-01-07

Lead Sponsor: University of New Mexico

Target Recruit Count: 22

Registration Number: NCT00276003

Locations: 🇺🇸
Lovelace Sandia Health Systems Dept of Hematology, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Exercise Induced Bronchospasm in Children

Phase 4

Completed

Conditions: Exercise Induced Bronchospasm

Interventions: Drug: montelukast vs pretreatment with albuterol
Drug: montelukast

First Posted Date: 2006-01-09

Last Posted Date: 2008-05-07

Lead Sponsor: University of New Mexico

Target Recruit Count: 13

Registration Number: NCT00273689

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors

Phase 1

Completed

Conditions: Brain and Nervous System
Cancer

First Posted Date: 2005-11-10

Last Posted Date: 2010-01-07

Lead Sponsor: University of New Mexico

Target Recruit Count: 10

Registration Number: NCT00251797

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study

Not Applicable

Terminated

Conditions: Cancer
Other Female Genital

First Posted Date: 2005-11-08

Last Posted Date: 2024-01-12

Lead Sponsor: University of New Mexico

Target Recruit Count: 15

Registration Number: NCT00250809

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Lung Cancer Case Registry and Tissue Resource

Terminated

Conditions: Lung Cancer

First Posted Date: 2005-11-08

Last Posted Date: 2024-01-08

Lead Sponsor: University of New Mexico

Target Recruit Count: 750

Registration Number: NCT00250848

Locations: 🇺🇸
New Mexico Veterans Administration Health Care System, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

Phase 2

Completed

Conditions: Liver
Cancer

Interventions: Drug: Thalidomide, alpha interferon
Drug: Thalidomide, interferon, Octreotide

First Posted Date: 2005-11-08

Last Posted Date: 2010-01-07

Lead Sponsor: University of New Mexico

Target Recruit Count: 12

Registration Number: NCT00250796

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States
🇺🇸
New Mexico Cancer Care Associates, Santa Fe, New Mexico, United States

Pre-Clinical Models in Gynecological Tumors A Tissue Repository

Completed

Conditions: Uterine Neoplasms
Endometrial Neoplasms

First Posted Date: 2005-11-08

Last Posted Date: 2024-03-12

Lead Sponsor: University of New Mexico

Target Recruit Count: 26

Registration Number: NCT00250783

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis

Withdrawn

Conditions: Endometrial Neoplasms
Uterine Neoplasms

First Posted Date: 2005-11-08

Last Posted Date: 2023-07-05

Lead Sponsor: University of New Mexico

Registration Number: NCT00250770

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Pharmacology Study of Aerosolized Liposomal

Phase 2

Withdrawn

Conditions: Cancer
Lung Diseases

First Posted Date: 2005-11-07

Last Posted Date: 2016-05-12

Lead Sponsor: University of New Mexico

Registration Number: NCT00250120

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)

Phase 2

Completed

Conditions: Lung Diseases
Cancer

First Posted Date: 2005-11-07

Last Posted Date: 2010-05-19

Lead Sponsor: University of New Mexico

Target Recruit Count: 8

Registration Number: NCT00250068

Locations: 🇺🇸
University of New Mexico, Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy